UBS Group
UROY

UBS Group’s Uranium Royalty Corp UROY Stock Holding History

UBS Group’s Portfolio UROY Stock Details UROY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Buy
584,664
+281,930
+93% +$989K ﹤0.01% 5298
2026
Q1 		$1.1M Sell
302,734
-103,959
-26% -$425K ﹤0.01% 5477
2025
Q4 		$1.44M Sell
406,693
-389,632
-49% -$1.52M ﹤0.01% 5255
2025
Q3 		$3.42M Buy
796,325
+19,604
+3% +$59.3K ﹤0.01% 4431
2025
Q2 		$1.94M Sell
776,721
-84,645
-10% -$171K ﹤0.01% 4855
2025
Q1 		$1.52M Buy
861,366
+59,007
+7% +$126K ﹤0.01% 4925
2024
Q4 		$1.76M Buy
802,359
+341,316
+74% +$877K ﹤0.01% 4842
2024
Q3 		$1.13M Buy
461,043
+19,607
+4% +$44.2K ﹤0.01% 4555
2024
Q2 		$993K Buy
441,436
+108,609
+33% +$270K ﹤0.01% 4430
2024
Q1 		$795K Buy
332,827
+21,824
+7% +$62K ﹤0.01% 4782
2023
Q4 		$840K Buy
311,003
+172,966
+125% +$485K ﹤0.01% 4656
2023
Q3 		$396K Buy
138,037
+28,972
+27% +$68.2K ﹤0.01% 4842
2023
Q2 		$218K Buy
109,065
+3,562
+3% +$7.09K ﹤0.01% 5417
2023
Q1 		$217K Buy
105,503
+1,088
+1% +$2.6K ﹤0.01% 5324
2022
Q4 		$247K Sell
104,415
-2,820
-3% -$6.87K ﹤0.01% 5288
2022
Q3 		$240K Sell
107,235
-60,478
-36% -$159K ﹤0.01% 4928
2022
Q2 		$381K Buy
167,713
+71,386
+74% +$229K ﹤0.01% 4467
2022
Q1 		$379K Sell
96,327
-1,351
-1% -$5.13K ﹤0.01% 4891
2021
Q4 		$357K Buy
97,678
+33,027
+51% +$151K ﹤0.01% 5250
2021
Q3 		$233K Buy
64,651
+1,313
+2% +$4.03K ﹤0.01% 5204
2021
Q2 		$190K Buy
+63,338
New +$189K ﹤0.01% 5391

Other funds holding UROY

Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AAG
Accordant Advisory Group Annapolis, Maryland $148M AUM 23.8% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
SI
Sprott Inc Toronto, Ontario, Canada $3.15B AUM 70.1% 1-Year Est. Return
SC
Simcoe Capital Spokane, Washington $164M AUM
VA
Vident Advisory Alpharetta, Georgia $13.9B AUM 53.47% 1-Year Est. Return

UBS Group's UROY Position: Q2 2026 in Review

UBS Group increased its Uranium Royalty Corp (UROY) stake by 93% in Q2 2026, buying an estimated $989K and bringing the position to 584,664 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #5298.

UBS Group first reported a position in UROY in Q2 2021 and has held it in 21 quarters since. The position peaked at $3.42M in Q3 2025. 112 funds tracked by Wall St. Rank hold UROY as of Q2 2026.

  • UBS Group held 584,664 shares of Uranium Royalty Corp worth $1.63M as of Q2 2026.
  • UBS Group bought 281,930 Uranium Royalty Corp shares in Q2 2026, an estimated $989K.
  • Uranium Royalty Corp made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #5298 holding.
  • UBS Group first reported a position in Uranium Royalty Corp in Q2 2021 and has held it in 21 quarters since.
  • UBS Group's Uranium Royalty Corp position peaked at $3.42M in Q3 2025.
  • 112 funds tracked by Wall St. Rank held Uranium Royalty Corp as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.